Cargando…

The Effectiveness of Lurasidone Add-On for Residual Aggressive Behavior and Obsessive Symptoms in Antipsychotic-Treated Children and Adolescents with Tourette Syndrome: Preliminary Evidence from a Case Series

Children and adolescents with Tourette syndrome may suffer from comorbid psychological and behavioral difficulties, primarily Attention-Deficit Hyperactivity Disorder-related manifestations including impulsive, aggressive, and disruptive behavior, and Obsessive-Compulsive Disorder-related disturbanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colizzi, Marco, Bortoletto, Riccardo, Zoccante, Leonardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915970/ https://www.ncbi.nlm.nih.gov/pubmed/33572131 http://dx.doi.org/10.3390/children8020121

Ejemplares similares

Antipsychotic treatments; focus on lurasidone
por: Sumiyoshi, Tomiki
Publicado: (2013)

Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence
por: Colizzi, Marco, et al.
Publicado: (2021)

Complex obsessive compulsive and impulsive symptoms in Tourette’s syndrome
por: Palumbo, Donna, et al.
Publicado: (2007)

Psychopharmacotherapy of Obsessive-Compulsive Symptoms within the Framework of Tourette Syndrome
por: Rothenberger, Aribert, et al.
Publicado: (2019)

Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report
por: Colizzi, Marco, et al.
Publicado: (2020)

Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone
por: Sood, Shabnam
Publicado: (2017)

The Effect of Atorvastatin on Obsessive-compulsive Symptoms of Refractory Obsessive-compulsive Disorder (Add-on Therapy)
por: Akouchekian, Shahla, et al.
Publicado: (2018)

Examining the functional activity of different obsessive–compulsive symptom dimensions in Tourette syndrome
por: Bhikram, Tracy, et al.
Publicado: (2020)

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
por: Loebel, Antony, et al.
Publicado: (2015)

Mild Decrease in Blood Glucose Levels May Predict Efficacy of Antipsychotic Lurasidone
por: Nagamine, Takahiko, et al.
Publicado: (2023)

Update on the role of antipsychotics in the treatment of Tourette syndrome
por: Huys, Daniel, et al.
Publicado: (2012)

Can Isolated Head Tremors Be an Extrapyramidal Symptom Associated with Lurasidone?—A Case Series
por: Suriya V,, et al.
Publicado: (2021)

21.5 Repercussions of the First and Second COVID-19 Waves in the Italian Pediatric Population: An Inpatient Psychiatric Emergency Study
por: Bortoletto, Riccardo, et al.
Publicado: (2021)

Which antipsychotics can we use for obsessive-compulsive symptoms in schizophrenia?
por: Aissa, A., et al.
Publicado: (2021)

Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder
por: Müller-Vahl, K. R., et al.
Publicado: (2019)

Trichotillomania is more related to Tourette disorder than to obsessive-compulsive disorder
por: Lamothe, Hugues, et al.
Publicado: (2019)

The Cerebellum in Drug-naive Children with Tourette Syndrome and Obsessive–Compulsive Disorder
por: Tikoo, Sankalp, et al.
Publicado: (2021)

An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine
por: Wu, Claire, et al.
Publicado: (2014)

Lurasidone hydrochloride
por: Zhang, Hua, et al.
Publicado: (2012)

Time estimation in a case of Tourette's syndrome: Effect of antipsychotic medications
por: Inagawa, Takuma, et al.
Publicado: (2020)

Pharmacological management of tourette's syndrome comorbid with obsessive-compulsive disorder in adult patients
por: Tyagi, Himanshu, et al.
Publicado: (2021)

Challenges in the Diagnosis and Assessment in Patients with Tourette Syndrome and Comorbid Obsessive-Compulsive Disorder
por: Szejko, Natalia, et al.
Publicado: (2021)

The shared genetic risk factors between Tourette syndrome and obsessive-compulsive disorder
por: Khoodoruth, Mohamed Adil Shah, et al.
Publicado: (2023)

Antipsychotic augmentation in the treatment of obsessive-compulsive disorder
por: Thamby, Abel, et al.
Publicado: (2019)

Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021
por: Bortoletto, Riccardo, et al.
Publicado: (2022)

Atypical antipsychotics as add-on treatment in late-life depression
por: Cakir, Sibel, et al.
Publicado: (2016)

Genome-wide sequencing for the identification of rearrangements associated with Tourette syndrome and obsessive-compulsive disorder
por: Hooper, Sean D, et al.
Publicado: (2012)

Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture
por: Davis, Lea K., et al.
Publicado: (2013)

Author Correction: Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder
por: Müller-Vahl, K. R., et al.
Publicado: (2020)

White matter alterations in drug-naïve children with Tourette syndrome and obsessive-compulsive disorder
por: Bharti, Komal, et al.
Publicado: (2022)

Lurasidone-induced Oculogyric Crisis
por: Das, Soumitra, et al.
Publicado: (2017)

Lurasidone-induced Parkinsonism and Hyperprolactinemia
por: Suthar, Navratan, et al.
Publicado: (2019)

Lurasidone in treatment of manic episode
por: Sánchez-Rivero, I.
Publicado: (2022)

Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis
por: Arango, Celso, et al.
Publicado: (2019)

Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia
por: Pochiero, Ilena, et al.
Publicado: (2021)

Changes in Sensory Phenomena, Tics, Obsessive–Compulsive Symptoms, and Global Functioning of Tourette Syndrome: A Follow-Up After Four Years
por: Kano, Yukiko, et al.
Publicado: (2020)

Efficacy of Behavioural Intervention, Antipsychotics, and Alpha Agonists in the Treatment of Tics Disorder in Tourette’s Syndrome
por: Rizwan, Muneeba, et al.
Publicado: (2022)

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study
por: Citrome, Leslie, et al.
Publicado: (2013)

Chronic Stress Exposure Reduces Parvalbumin Expression in the Rat Hippocampus through an Imbalance of Redox Mechanisms: Restorative Effect of the Antipsychotic Lurasidone
por: Rossetti, Andrea C, et al.
Publicado: (2018)

Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia
por: Correll, Christoph U., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l1646c70o87b118m5fl5u6im2e